Cargando…
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683913/ https://www.ncbi.nlm.nih.gov/pubmed/26683050 http://dx.doi.org/10.1186/s12974-015-0450-1 |
_version_ | 1782406112448872448 |
---|---|
author | Wuhrer, Manfred Selman, Maurice H. J. McDonnell, Liam A. Kümpfel, Tania Derfuss, Tobias Khademi, Mohsen Olsson, Tomas Hohlfeld, Reinhard Meinl, Edgar Krumbholz, Markus |
author_facet | Wuhrer, Manfred Selman, Maurice H. J. McDonnell, Liam A. Kümpfel, Tania Derfuss, Tobias Khademi, Mohsen Olsson, Tomas Hohlfeld, Reinhard Meinl, Edgar Krumbholz, Markus |
author_sort | Wuhrer, Manfred |
collection | PubMed |
description | BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in MS and in cerebrospinal fluid (CSF) in general. METHODS: We applied mass spectrometry of tryptic Fc glycopeptides to analyze IgG Fc glycosylation (sialylation, galactosylation, fucosylation, and bisecting N-acetylglucosamine (GlcNAc)) in 48 paired CSF and serum samples from adult patients with MS or a first demyelinating event highly suggestive of MS (designated as MS cases), and from healthy volunteers and patients with other non-inflammatory diseases (control group). p values were adjusted for multiple testing. RESULTS: Our experiments revealed four main results. First, IgG1 glycosylation patterns were different in CSF vs. serum, in the MS group and even in control donors without intrathecal IgG synthesis. Second, in MS patients vs. controls, IgG1 glycosylation patterns were altered in CSF, but not in serum. Specifically, in CSF from the MS group, bisecting GlcNAc were elevated, and afucosylation and galactosylation were reduced. Elevated bisecting GlcNAc and reduced galactosylation are known to enhance IgG effector functions. Third, hypothesis-free regression analysis revealed that alterations of afucosylation and bisecting GlcNAc in CSF from MS cases peaked 2–3 months after the last relapse. Fourth, CSF IgG1 glycosylation correlated with the degree of intrathecal IgG synthesis and CSF cell count. CONCLUSIONS: The CNS compartment as well as the inflammatory milieu in MS affect IgG1 Fc glycosylation. In MS, the CSF IgG1 glycosylation has features that enhance Fc effector functions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0450-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4683913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46839132015-12-19 Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid Wuhrer, Manfred Selman, Maurice H. J. McDonnell, Liam A. Kümpfel, Tania Derfuss, Tobias Khademi, Mohsen Olsson, Tomas Hohlfeld, Reinhard Meinl, Edgar Krumbholz, Markus J Neuroinflammation Research BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in MS and in cerebrospinal fluid (CSF) in general. METHODS: We applied mass spectrometry of tryptic Fc glycopeptides to analyze IgG Fc glycosylation (sialylation, galactosylation, fucosylation, and bisecting N-acetylglucosamine (GlcNAc)) in 48 paired CSF and serum samples from adult patients with MS or a first demyelinating event highly suggestive of MS (designated as MS cases), and from healthy volunteers and patients with other non-inflammatory diseases (control group). p values were adjusted for multiple testing. RESULTS: Our experiments revealed four main results. First, IgG1 glycosylation patterns were different in CSF vs. serum, in the MS group and even in control donors without intrathecal IgG synthesis. Second, in MS patients vs. controls, IgG1 glycosylation patterns were altered in CSF, but not in serum. Specifically, in CSF from the MS group, bisecting GlcNAc were elevated, and afucosylation and galactosylation were reduced. Elevated bisecting GlcNAc and reduced galactosylation are known to enhance IgG effector functions. Third, hypothesis-free regression analysis revealed that alterations of afucosylation and bisecting GlcNAc in CSF from MS cases peaked 2–3 months after the last relapse. Fourth, CSF IgG1 glycosylation correlated with the degree of intrathecal IgG synthesis and CSF cell count. CONCLUSIONS: The CNS compartment as well as the inflammatory milieu in MS affect IgG1 Fc glycosylation. In MS, the CSF IgG1 glycosylation has features that enhance Fc effector functions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0450-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-18 /pmc/articles/PMC4683913/ /pubmed/26683050 http://dx.doi.org/10.1186/s12974-015-0450-1 Text en © Wuhrer et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wuhrer, Manfred Selman, Maurice H. J. McDonnell, Liam A. Kümpfel, Tania Derfuss, Tobias Khademi, Mohsen Olsson, Tomas Hohlfeld, Reinhard Meinl, Edgar Krumbholz, Markus Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title_full | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title_fullStr | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title_full_unstemmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title_short | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
title_sort | pro-inflammatory pattern of igg1 fc glycosylation in multiple sclerosis cerebrospinal fluid |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683913/ https://www.ncbi.nlm.nih.gov/pubmed/26683050 http://dx.doi.org/10.1186/s12974-015-0450-1 |
work_keys_str_mv | AT wuhrermanfred proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT selmanmauricehj proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT mcdonnellliama proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT kumpfeltania proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT derfusstobias proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT khademimohsen proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT olssontomas proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT hohlfeldreinhard proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT meinledgar proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid AT krumbholzmarkus proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid |